Wednesday, June 10, 2026

pharma Β· Pulmonary Embolism Β· Carcinoma, Hepatocellular

Bayer HealthCare Animal

Bayer HealthCare Animal clinical programs β€” 34 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

3915 S 48TH STREET TER, St. Joseph, Missouri 64503, us HQ
1919 Founded
8 Employees
EMA registrant Type
Company details
Status
Public
HQ
3915 S 48TH STREET TER, St. Joseph, Missouri 64503, us
Founded
1919
Employees
8
Programs
34
Drugs
32
Patents
24
Intelligence Β· Clinical Programs

Bayer HealthCare Animal projects

34 ClinicalTrials.gov programs sponsored by Bayer HealthCare Animal.

Bayer HealthCare Animal has 34 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 15161

    Bayer HealthCare AG

    Macular Edema

    phase 3 mab completed

    1 trial
  2. 91774

    Bayer HealthCare AG

    Metrorrhagia

    phase 3 small molecule completed

    1 trial
  3. 91781

    Bayer HealthCare AG

    Primary Dysmenorrhea

    phase 3 small molecule completed

    1 trial
  4. 91782

    Bayer HealthCare AG

    Breast Cancer

    phase 3 small molecule completed

    1 trial
  5. Asundexian (BAY2433334)

    Bayer HealthCare AG

    Prevention of Ischemic Stroke

    phase 3 small molecule completed

    1 trial
  6. Asundexian (BAY2433334)

    Bayer HealthCare AG

    Prevention of Stroke or Systemic Embolism

    phase 3 small molecule terminated

    1 trial
  7. BAY 59-7939

    Bayer HealthCare AG

    Pulmonary Embolism

    phase 3 small molecule completed

    1 trial
  8. BAY94-9027

    Bayer HealthCare AG

    Hemophilia A

    phase 3 mab completed

    1 trial
  9. Ciprofloxacin (BAYQ3939) dry powder for inhalation

    Bayer HealthCare AG

    Bronchiectasis

    phase 3 small molecule completed

    1 trial
  10. Copanlisib (Aliqopa, BAY80-6946)

    Bayer HealthCare AG

    Lymphoma,Non-Hodgkin

    phase 3 small molecule completed

    1 trial
  11. EV/DNG (Qlaira, BAY86-5027)

    Bayer HealthCare AG

    Oral Contraceptive

    phase 3 small molecule completed

    1 trial
  12. Finerenone (BAY94-8862)

    Bayer HealthCare AG

    Chronic Kidney Disease

    phase 3 small molecule completed

    1 trial
  13. Finerenone (BAY94-8862)

    Bayer HealthCare AG

    Diabetic Kidney Disease

    phase 3 small molecule completed

    1 trial
  14. Finerenone (BAY94-8862)

    Bayer HealthCare AG

    Heart Failure

    phase 3 small molecule completed

    1 trial
  15. Nifedipine (Adalat, BAYA1040)

    Bayer HealthCare AG

    Hypertension

    phase 3 small molecule completed

    1 trial
  16. Recombinant Factor VIII (BAY81-8973)

    Bayer HealthCare AG

    Blood Coagulation Disorders

    phase 3 mab completed

    1 trial
  17. Regorafenib (BAY73-4506)

    Bayer HealthCare AG

    Colorectal Neoplasms

    phase 3 small molecule completed

    1 trial
  18. Rivaroxaban (Xarelto, BAY59-7939)

    Bayer HealthCare AG

    Venous Thromboembolism

    phase 3 small molecule completed

    2 trials
  19. Rivaroxaban (Xarelto, BAY59-7939)

    Bayer HealthCare AG

    Prevention & Control

    phase 3 small molecule completed

    1 trial
  20. Rivaroxaban (Xarelto, BAY59-7939)

    Bayer HealthCare AG

    Pulmonary Embolism

    phase 3 small molecule completed

    1 trial
  21. Sevabertinib

    Bayer HealthCare AG

    Advanced Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial
  22. Sorafenib (Nexavar, BAY43-9006)

    Bayer HealthCare AG

    Carcinoma, Hepatocellular

    phase 3 small molecule completed

    1 trial
  23. Sorafenib (Nexavar, BAY43-9006)

    Bayer HealthCare AG

    Carcinoma

    phase 3 small molecule completed

    1 trial
  24. Tedizolid (BAY119-2631)

    Bayer HealthCare AG

    Bacterial Infections

    phase 3 small molecule completed

    1 trial
  25. YAZ (SH T00186, BAY86-5300)

    Bayer HealthCare AG

    Contraception

    phase 3 small molecule completed

    1 trial
  26. 91396

    Bayer HealthCare AG

    Magnetic Resonance Angiography

    phase 2 small molecule completed

    1 trial
  27. BAY1002670

    Bayer HealthCare AG

    Leiomyoma

    phase 2 small molecule completed

    1 trial
  28. BAY2757556 (Larotrectinib, Vitrakvi)

    Bayer HealthCare AG

    Solid Tumors Harboring NTRK Fusion

    phase 2 small molecule completed

    1 trial
  29. Radium-223 dichloride (Xofigo, BAY88-8223)

    Bayer HealthCare AG

    Breast Neoplasms

    phase 2 small molecule completed

    1 trial
  30. Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin

    Bayer HealthCare AG

    Carcinoma, Hepatocellular

    phase 2 small molecule completed

    1 trial
  31. BAY2965501

    Bayer HealthCare AG

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial
  32. Ciprofloxacin (Cipro InhaIe, BAYQ3939)

    Bayer HealthCare AG

    Pulmonary Disease, Chronic Obstructive

    phase 1 small molecule completed

    1 trial
  33. Elimusertib (BAY1895344)

    Bayer HealthCare AG

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial
  34. Refametinib (BAY86-9766)

    Bayer HealthCare AG

    Neoplasms

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Bayer HealthCare Animal have?

34 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.